NovaBay Pharmaceuticals, Inc. (NBY): insider trading, Congress trades & who owns it

Insider signal
50/100
Neutral · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
—
13F filings
Congress trades
None
none in 2 years

Quiet on the insider front: nobody at NovaBay Pharmaceuticals, Inc. bought or sold NBY shares on the open market this past year.

Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters.

Want the full picture on NBY? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full NBY report — free account

Latest insider trades in NBY

FiledInsiderRoleTypeSharesPriceValueSource
Apr 15, 2025FAKHRY JAD10% OwnerBuy300$0.47$141SEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy4,538$0.52$2KSEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy22,976$0.56$13KSEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy917$0.58$532SEC
Apr 15, 2025POPLAR POINT CAPITAL PARTNERS LP10% OwnerBuy21,654$0.59$13KSEC
Apr 15, 2025POPLAR POINT CAPITAL PARTNERS LP10% OwnerBuy19,915$0.59$12KSEC
Apr 15, 2025POPLAR POINT CAPITAL PARTNERS LP10% OwnerBuy49,400$0.61$30KSEC
Apr 15, 2025POPLAR POINT CAPITAL PARTNERS LP10% OwnerBuy600$0.61$366SEC
Apr 15, 2025POPLAR POINT CAPITAL PARTNERS LP10% OwnerBuy18,504$0.62$11KSEC
Apr 15, 2025POPLAR POINT CAPITAL PARTNERS LP10% OwnerBuy13,292$0.61$8KSEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy1,500$0.60$900SEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy14,000$0.63$9KSEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy5,320$0.61$3KSEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy6,372$0.61$4KSEC
Apr 15, 2025FAKHRY JAD10% OwnerBuy100$0.61$61SEC

Questions about NBY

Are insiders buying or selling NBY stock?

There were no open-market insider trades in NBY in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

Has any member of Congress traded NBY?

No congressional trades in NBY were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).